in ,

B3 Solutions Selected for JPEO Chem-Bio Defense Omnibus Support

B3 Solutions, LLC. this week announced it has been awarded a prime position on the Acquisition Domain of the Omnibus Program Engineering and Technical Support contract supporting the development and fielding of chemical and biological defense materiel for the Department of Defense Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD).

The five-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract expands B3 Solutions’ presence at JPEO-CBD. Including B3 Solutions, there are 22 awardees in the Acquisition Domain. All awardees have the potential to receive the full value amount of the IDIQ contract if all options are exercised.

B3 Solutions will compete for JPEO-CBD task orders to provide acquisition, program management and relations management in CBD and national security communities, strategic planning, program analysis, life cycle management, international program analysis on foreign military sales, equipment expertise on the production and usage of CBD protective equipment, multimedia, graphics, technical writing support, and administrative support.

“We look forward to providing the critical expertise required to help develop chemical and biological defense solutions,” said William Almas, B3 Solutions CEO. “Nothing is more important than keeping our armed forces and civilians out of harm’s way.”

The JPEO-CBD is responsible for research, development and acquisition support of chemical, biological, radiological, and nuclear defense equipment and medical countermeasures for missions overseas and at home.

Source: B3 Solutions 

Anthrax Vaccine Trial for Kids? The Ethics of Pediatric Countermeasures Research

NHRC Provides Modeling Solutions for Joint Medical Planners